RefleXion Medical Announces First Clinical Outcomes for SCINTIX Therapy in Lung and Bone Tumors
HAYWARD, Calif.–(BUSINESS WIRE)–#BGRT—RefleXion Medical, an external‑beam theranostic oncology company, today announced first results from the PREMIER Registry (NCT05406167) evaluating its SCINTIX® biology-guided radiotherapy, or BgRT, platform in patients with lung and bone tumors. The findings, presented at the 2025 ASTRO Annual Meeting, showed local control of 100 percent at nine months post-treatment with no reported … [Read more…]
